Thomas Leggett

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Jonathan Allan, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Thomas Leggett:

Company Role Class Num Shares Value Price $ Report Date Ownership
Stoke Therapeutics, Inc. Chief Financial Officer Restricted Stock Units 40,000 $487,930 $8.27 17 Feb 2026 Direct
Stoke Therapeutics, Inc. Chief Financial Officer Employee Stock Option (Right to Buy) 60,000 17 Feb 2026 Direct

Insider Reports Filed by Thomas Leggett

Symbol Company Period Transactions Value $ Form Type Role Filing Time
STOK Stoke Therapeutics, Inc. 17 Feb 2026 2 $0 4 Chief Financial Officer 19 Feb 2026, 16:22
STOK Stoke Therapeutics, Inc. 20 Mar 2025 2 $0 4 Chief Financial Officer 20 Mar 2025, 18:17
STOK Stoke Therapeutics, Inc. 15 May 2024 1 $0 4 Chief Financial Officer 17 May 2024, 16:14
STOK Stoke Therapeutics, Inc. 07 May 2024 0 $0 3 Chief Financial Officer 17 May 2024, 16:12